BloodGPT
PrivateLast Round
Seed
Jun 16, 2025
Est. Valuation
$10M
Total Funding Raised
$1M
Company Overview
BloodGPT operates in Healthcare & Life Sciences and is based in Nicosia. Its latest recorded funding round was a Seed round in June 2025.
BloodGPT is a healthtech company that provides an AI-powered platform for diagnostic laboratories, clinics, and individuals to interpret blood test results.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Healthcare Analytics, Patient Engagement, NLP & Conversational AI
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BloodGPT Comparables
Compare BloodGPT with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Medicus AI | 86% | |
| Kantesti | 84% | |
| Dr. Max Health | 78% |
For institutional investors. Book with your work email.
BloodGPT Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 2, 2026
Monthly visitors grew 89% MoM, reaching 14.4K.
- Jan 5, 2026
Monthly visitors grew 88% MoM.
For institutional investors. Book with your work email.
BloodGPT Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about BloodGPT's valuation, stock price, and market status.
Is BloodGPT a public or private company?
BloodGPT is a private company.
What is the current stock price of BloodGPT?
BloodGPT is a private company, so its shares have no public market price. Caplight tracks BloodGPT's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is BloodGPT worth (valuation)?
BloodGPT's valuation is estimated at $10.0M based on funding round data.
Can I buy BloodGPT stock?
BloodGPT shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was BloodGPT's last funding round?
BloodGPT's most recent funding round was Seed on June 16, 2025.
Who are the main investors in BloodGPT?
Investor information for BloodGPT is not publicly disclosed.
Will BloodGPT IPO soon?
No public IPO plans have been announced for BloodGPT.
How can I track BloodGPT secondary market activity?
Caplight tracks bids, offers, and trades in BloodGPT's shares on secondary markets.